A clinical trial on VELLARIVITHAI CHOORANAM in the management of KALLADAIPPU (UROLITHIASIS)

A Prospective Open Labelled Non-randomized Phase II clinical trial of VELLARIVITHAI CHOORANAM in the management of KALLADAIPPU (UROLITHIASIS)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031216

Enrollment

Registered

2021-02-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

Intervention1: VELLARIVITHAI CHOORANAM: 5g twice a day after meals for 45 days in 60 patients Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Evidence of renal calculus , confirmed by USG Renal colicky pain:loin to groin Nausea, vomiting and sweating Haematuria Oliguria Dysuria

Exclusion criteria

Exclusion criteria: Chronic appendicitis Cholecystitis Pyelonephritis Recurrent UTI Diabetes mellitus Hyperthyroidism,hyperparathyroidism Pelvic inflammatory disease Chronic renal failure

Design outcomes

Primary

Measure	Time frame
Reduction in severity of renal colicky pain,nausea, vomiting, haematuria,dysuria,pyuria and oliguria Kidney stone is expelled to come out as such or disintegrated and mixed with urine will be ensuredTimepoint: 45 days	—

Secondary

Measure	Time frame
Reduction in size of the kidney stone in USG abdomen and pelvisTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDrAManoharan MDSPhD

Government Siddha Medical College and Hospital

komalaarumugam1@gmail.com8248497477

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026